Whitney S. Loo

Whitney S. Loo

Auto-generated profile, based on publicly available information

Whitney S. Loo

University of Wisconsin−Madison

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2015 in Nature Materials
Verified
Journal Article
Open access
PDF file
OVOmid Veiseh
Omid Veiseh
JDJoshua Doloff
Joshua Doloff
MMMinglin Ma
Minglin Ma
AVArturo J. Vegas
Arturo J. Vegas
HTHok Hei Tam
Hok Hei Tam
DADaniel G. Anderson
Daniel G. Anderson
The efficacy of implanted biomedical devices is often compromised by host recognition and subsequent foreign body responses. Here, we demonstrate the role of the geometry of implanted materials on their biocompatibility in vivo. In rodent and non-human primate animal models, implanted spheres 1.5 mm and above in diameter across a broad spectrum of materials, including hydrogels, ceramics, metals and plastics, significantly abrogated foreign body reactions and fibrosis when compared with smaller spheres. We also show that for encapsulated rat pancreatic islet cells transplanted into streptozotocin-treated diabetic C57BL/6 mice, islets prepared in 1.5-mm alginate capsules were able to restore blood-glucose control for up to 180 days, a period more than five times longer than for transplanted grafts encapsulated within conventionally sized 0.5-mm alginate capsules. Our findings suggest that the in vivo biocompatibility of biomedical devices can be significantly improved simply by tuning their spherical dimensions.

10 November 2022 in Nature Materials
Verified
Journal Article
Closed access
PDF file
HFHongbo Feng
Hongbo Feng
MDMoshe Dolejsi
Moshe Dolejsi
NZNing Zhu
Ning Zhu
SYSoonmin Yim
Soonmin Yim
WLWhitney Loo
Whitney Loo
PNPaul F. Nealey
Paul F. Nealey

1 August 2018 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
WLWhitney S. Loo
Whitney S. Loo
MGMichael D. Galluzzo
Michael D. Galluzzo
XLXiuhong Li
Xiuhong Li
JMJacqueline Avery Maslyn
Jacqueline Avery Maslyn
HOHee Jeung Oh
Hee Jeung Oh
NBNitash P. Balsara
Nitash P. Balsara

22 January 2020 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
MGMichael D. Galluzzo
Michael D. Galluzzo
WLWhitney S. Loo
Whitney S. Loo
AWAndrew A. Wang
Andrew A. Wang
AWAmber Walton
Amber Walton
JMJacqueline A. Maslyn
Jacqueline A. Maslyn
NBNitash P. Balsara
Nitash P. Balsara

13 November 2018 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
JMJacqueline A. Maslyn
Jacqueline A. Maslyn
WLWhitney S. Loo
Whitney S. Loo
KMKyle D. McEntush
Kyle D. McEntush
HOHee Jeung Oh
Hee Jeung Oh
KHKatherine J. Harry
Katherine J. Harry
NBNitash P. Balsara
Nitash P. Balsara

9 January 2019 in ACS Central Science
Verified
Journal Article
Open access
HOHee Jeung Oh
Hee Jeung Oh
MAMariam S. Aboian
Mariam S. Aboian
MYMichael Y. J. Yi
Michael Y. J. Yi
JMJacqueline A. Maslyn
Jacqueline A. Maslyn
WLWhitney S. Loo
Whitney S. Loo
NBNitash P. Balsara
Nitash P. Balsara
Despite efforts to develop increasingly targeted and personalized cancer therapeutics, dosing of drugs in cancer chemotherapy is limited by systemic toxic side effects. We have designed, built, and deployed porous absorbers for capturing chemotherapy drugs from the bloodstream after these drugs have had their effect on a tumor, but before they are released into the body where they can cause hazardous side effects. The support structure of the absorbers was built using 3D printing technology. This structure was coated with a nanostructured block copolymer with outer blocks that anchor the polymer chains to the 3D printed support structure and a middle block that has an affinity for the drug. The middle block is polystyrenesulfonate which binds to doxorubicin, a widely used and effective chemotherapy drug with significant toxic side effects. The absorbers are designed for deployment during chemotherapy using minimally invasive image-guided endovascular surgical procedures. We show that the introduction of the absorbers into the blood of swine models enables the capture of 64 ± 6% of the administered drug (doxorubicin) without any immediate adverse effects. Problems related to blood clots, vein wall dissection, and other biocompatibility issues were not observed. This development represents a significant step forward in minimizing toxic side effects of chemotherapy.